UNSPSC 51391746: Racepinefrine or racepinephrine

This classification denotes a bronchodilator with the molecular formula C9H13NO3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 336096P2WE. European Medicines Agency schedules racepinephrine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33967. The term racepinephrine hydrochloride is a UNSPSC designation. Racepinefrine or racepinephrine bears US NLM identifiers UMLS ID C0205758 and NCI Concept Code C76546. SMILES: CNCC(C1=CC(=C(C=C1)O)O)O.CL.

UNSPSC 51391746 Racepinephrine (Commodity) reflects pharmaceutical procurement at the state and local level, though recent activity under this specific code shows minimal direct correlation with the code's narrow scope. The two recent opportunities posted under this code involve naloxone procurement by Seminole County, Florida and a Request for Information from Texas Health and Human Services Commission regarding direct-to-manufacturer prescription programs — neither of which targets racepinephrine specifically. State and local health departments, county health systems, and state pharmacy benefit programs are the primary issuing bodies when pharmaceutical procurements surface under broader health-services codes, but activity directly under this Commodity code appears sparse and misdirected relative to its nominal product specification.

Recent opportunities show geographic activity concentrated in Florida and Texas. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023 (note: date appears inconsistent with posting date); vendors must include shipping and delivery costs and comply with E-Verify and drug-free workplace requirements, with contract awards on a fixed-fee basis and an initial two-year term plus one-year renewal option. Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, gathering vendor intelligence on direct-to-manufacturer prescription fulfillment programs rather than spot procurement. The mismatch between the code's specificity (racepinephrine) and the actual solicitation scope (general naloxone and pharmacy benefit program infrastructure) suggests that this Commodity code captures little actionable state and local procurement activity and may warrant review for recoding accuracy.